Pharmafile Logo
Pharmafocus logo
Advanced Search

White paper

Showing 15 posts of 23 posts found.

High potency drugs – from molecule to market

June 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI

To print or download a PDF version of this article, click here.

Feature
White paper

Tau pathology as the key to understanding Alzheimer’s disease

June 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common type of dementia (60–70%)[1], causing problems with memory, language, …

Feature
White paper

Clinical Trial Success: How Relationships Are Key

June 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing contract research organisations, cros

Jeffrey Zucker, Vice President of Feasibility and Recruitment Optimisation at Worldwide Clinical Trials, offers strategies for establishing and maintaining key …

Feature
White paper

Europe vs USA: New drug approvals

June 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, regulatory affairs

Dr Terese Johansson, Regulatory Affairs Consultant NDA Group AB, examines the drop in US approvals while observing no similar trend …

Feature
White paper

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

March 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI services

Introduction More than three years have passed since the US federal government signed the Drug Supply Chain Security Act (DSCSA) …

Feature
White paper

Cmed release Global Strategic and Regulatory Consulting Booklet

March 14, 2012
Research and Development

The regulatory environments within the industry continue to change and vary internationally. Cmed’s regulatory and medical professionals keep track of …

Feature
Press release
White paper

Introducing SHL’s first White Paper: “Auto Injectors: From Planning to Launch”

January 3, 2012
Manufacturing and Production auto injector, autoinjector, autoinjector manufacturing, autoinjector white paper, shl white paper

SHL is officially introducing the company’s first White Paper on the topic of “Auto Injectors; From Planning to Launch” with …

Feature
White paper

Adaptive Trial Design

November 24, 2011
Research and Development

Despite the burgeoning interest in Adaptive Trial Design (ATD), an extremely powerful tool when used effectively in the appropriate circumstances, …

Feature
White paper

The Project Management Office – Accelerating Project Management Maturity

February 3, 2011
Sales and Marketing Kinapse, White paper

Success in the life sciences industry depends on allocation of scarce resource to the right projects at different stages of …

Feature
White paper

Offshore outsourcing in Regulatory Affairs and Pharmacovigilance

November 22, 2010
Sales and Marketing Kinapse, White paper

Based on Kinapse’s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore outsourcing within the biopharmaceutical industry …

Feature
White paper

New Commercial Realities

November 4, 2010
Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, pharmaceutical companies must undertake a fundamental and …

Feature
White paper

Sowing into Good Ground: Using “personalized medicine” for optimal treatment value

October 26, 2010
Sales and Marketing Kinapse, White paper

As demonstrating value for the “average patient” becomes ever more difficult, Health Economics and Outcomes Research leaders can use “personalised …

Feature
White paper

In with the ‘new’: A leaner, fitter biosciences sector – 2010

October 18, 2010
Sales and Marketing Kinapse, White paper

The biosciences sector has witnessed numerous challenges during recent years, as the global economic downturn has adversely impacted sector liquidity …

Feature
White paper

Discovery Innovation – Productive Partnering For Shared Success

October 15, 2010
Sales and Marketing Kinapse, White paper

Partnering is an integral feature within today’s pharmaceutical industry. While the conventional wisdom suggests that Phase II represents the optimum …

Feature
White paper

New Commercial Realities – Part 4 Key implications of this changing industry landscape for pharmaceutical commercial operations – governance

October 5, 2010
Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

Feature
White paper

Latest content

FDA grants ODD to Nexcella’s NXC-201 as treatment for amyloid light chain amyloidosis

September 22, 2023

AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan performs well in phase 3 trial

September 22, 2023

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023